NCT00255372 - To Determine the Effect of Forlax® Treatment in Children With Chronic Constipation Who May Also Suffer From Soiling/ Faecal Incontinence. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

May 20, 2008

Study Completion Date

May 20, 2008

Conditions

Chronic Constipation

Interventions

DRUG

PEG 4000 (Forlax®)

Powder for oral solution. 2 sachets of 4g, from baseline every two weeks over a 4 week treatment period.

DRUG

Lactulose active and Lactulose placebo

Powder for oral solution. 1 sachet of 3.3g lactulose active and 1 sachet of lactulose placebo. From baseline every two weeks over a 4 week treatment period.

Trial Locations (2)

10400

Ramathibodi Hospital, Mahidol University,, Bangkok

30000

Maharat Nakhon Ratchasima Hospital, Nakhon Ratchasima